AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 13.34 USD 1.83% Market Closed
Market Cap: 587.1m USD
Have any thoughts about
AxoGen Inc?
Write Note

Wall Street
Price Targets

AXGN Price Targets Summary
AxoGen Inc

Wall Street analysts forecast AXGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXGN is 17.92 USD with a low forecast of 16.16 USD and a high forecast of 21 USD.

Lowest
Price Target
16.16 USD
21% Upside
Average
Price Target
17.92 USD
34% Upside
Highest
Price Target
21 USD
57% Upside
AxoGen Inc Competitors:
Price Targets
TNDM
Tandem Diabetes Care Inc
77% Upside
CREO
Creo Medical Group PLC
253% Upside
AORT
Artivion Inc
20% Upside
ENOV
Enovis Corp
48% Upside
6823
Rion Co Ltd
43% Upside
SRDX
Surmodics Inc
12% Upside
ABT
Abbott Laboratories
13% Upside
ZBH
Zimmer Biomet Holdings Inc
15% Upside

Revenue
Forecast

Revenue Estimate
AxoGen Inc

For the last 8 years the compound annual growth rate for AxoGen Inc's revenue is 25%. The projected CAGR for the next 3 years is 15%.

25%
Past Growth
15%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat

Net Income
Forecast

Net Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
50%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXGN's stock price target?
Price Target
17.92 USD

According to Wall Street analysts, the average 1-year price target for AXGN is 17.92 USD with a low forecast of 16.16 USD and a high forecast of 21 USD.

What is AxoGen Inc's Revenue forecast?
Projected CAGR
15%

For the last 8 years the compound annual growth rate for AxoGen Inc's revenue is 25%. The projected CAGR for the next 3 years is 15%.

Back to Top